SK10072002A3 - Indolové deriváty ako antagonisty MCP-1 receptora - Google Patents

Indolové deriváty ako antagonisty MCP-1 receptora Download PDF

Info

Publication number
SK10072002A3
SK10072002A3 SK1007-2002A SK10072002A SK10072002A3 SK 10072002 A3 SK10072002 A3 SK 10072002A3 SK 10072002 A SK10072002 A SK 10072002A SK 10072002 A3 SK10072002 A3 SK 10072002A3
Authority
SK
Slovakia
Prior art keywords
carboxylic acid
trifluoromethyl
hydroxyindole
compound
chlorobenzyl
Prior art date
Application number
SK1007-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Alan Wellington Faull
Jason Grant Kettle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK10072002A3 publication Critical patent/SK10072002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SK1007-2002A 2000-01-13 2001-01-11 Indolové deriváty ako antagonisty MCP-1 receptora SK10072002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000626.2A GB0000626D0 (en) 2000-01-13 2000-01-13 Chemical compounds
PCT/GB2001/000069 WO2001051466A1 (en) 2000-01-13 2001-01-11 Indole derivatives as mcp-1 receptor antagonists

Publications (1)

Publication Number Publication Date
SK10072002A3 true SK10072002A3 (sk) 2003-06-03

Family

ID=9883551

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1007-2002A SK10072002A3 (sk) 2000-01-13 2001-01-11 Indolové deriváty ako antagonisty MCP-1 receptora

Country Status (25)

Country Link
US (1) US20030144339A1 (et)
EP (1) EP1252142A1 (et)
JP (1) JP2003519683A (et)
KR (1) KR20020064375A (et)
CN (1) CN1395565A (et)
AR (1) AR026839A1 (et)
AU (1) AU780992B2 (et)
BG (1) BG106894A (et)
BR (1) BR0107404A (et)
CA (1) CA2393592A1 (et)
CO (1) CO5271703A1 (et)
EE (1) EE200200394A (et)
GB (1) GB0000626D0 (et)
HK (1) HK1049486A1 (et)
HU (1) HUP0300694A3 (et)
IL (1) IL150272A0 (et)
IS (1) IS6429A (et)
MX (1) MXPA02006611A (et)
NO (1) NO20023380L (et)
NZ (1) NZ519312A (et)
PL (1) PL356031A1 (et)
RU (1) RU2002121636A (et)
SK (1) SK10072002A3 (et)
WO (1) WO2001051466A1 (et)
ZA (1) ZA200204354B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
WO2004069809A1 (en) 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
JP4945243B2 (ja) * 2004-09-13 2012-06-06 株式会社クレハ 熱発泡性マイクロスフェアー、その製造方法、その使用、それを含む組成物、及び物品
CA2631128A1 (en) 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
ES2550753T3 (es) * 2007-04-16 2015-11-12 Abbvie Inc. Derivados de indol no sustituidos en la posición 7 como inhibidores de Mcl-1
WO2023224981A1 (en) * 2022-05-17 2023-11-23 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5273980A (en) * 1991-09-30 1993-12-28 Merck Frosst Canada Inc. Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5686481A (en) * 1993-12-21 1997-11-11 Smithkline Beecham Corporation Endothelin receptor antagonists
US5482960A (en) * 1994-11-14 1996-01-09 Warner-Lambert Company Nonpeptide endothelin antagonists
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
JP2000507556A (ja) * 1996-03-28 2000-06-20 スミスクライン・ビーチャム・コーポレイション ケモカインのカルボン酸インドール阻害剤
AU4054197A (en) * 1996-08-14 1998-03-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803226D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
EE200200394A (et) 2003-12-15
HUP0300694A2 (hu) 2003-07-28
MXPA02006611A (es) 2002-09-30
RU2002121636A (ru) 2004-01-10
NO20023380D0 (no) 2002-07-12
NO20023380L (no) 2002-09-03
NZ519312A (en) 2004-04-30
ZA200204354B (en) 2003-09-01
WO2001051466A1 (en) 2001-07-19
IS6429A (is) 2002-06-19
PL356031A1 (en) 2004-06-14
HUP0300694A3 (en) 2005-08-29
EP1252142A1 (en) 2002-10-30
HK1049486A1 (zh) 2003-05-16
GB0000626D0 (en) 2000-03-01
CN1395565A (zh) 2003-02-05
BG106894A (bg) 2003-04-30
BR0107404A (pt) 2002-10-08
KR20020064375A (ko) 2002-08-07
CA2393592A1 (en) 2001-07-19
IL150272A0 (en) 2002-12-01
CO5271703A1 (es) 2003-04-30
JP2003519683A (ja) 2003-06-24
US20030144339A1 (en) 2003-07-31
AR026839A1 (es) 2003-02-26
AU2532401A (en) 2001-07-24
AU780992B2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
RU2235090C2 (ru) Производные индола и их применение в качестве антагонистов мср-1
US6833387B1 (en) Chemical compounds
EP1150953B1 (en) Indole derivatives and their use as mcp-1 receptor antagonists
EP1150954B1 (en) Anti-imflammatory indole derivatives
EP1001935B1 (en) Indole derivatives as mcp-1 receptor antagonists
EP1159269B1 (en) Anti-imflammatory indole derivatives
EP1054667B1 (en) Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
SK284408B6 (sk) Chemické zlúčeniny s protizápalovou aktivitou obsahujúce indolovú skupinu, spôsob ich prípravy, použitie a farmaceutické kompozície, ktoré ich obsahujú
SK10072002A3 (sk) Indolové deriváty ako antagonisty MCP-1 receptora
AU779502B2 (en) Indole derivatives as MCP-1 receptor antagonists
MXPA00007733A (es) Compuestos quimicos